Clinical Trials Directory

Trials / Completed

CompletedNCT04086095

Feasibility Study - Neofact

Feasibility Study - Neofact Feasibility Study of the Application Aid Neofact (Formerly: QuickSF) in the Less Invasive Surfactant Administration (LISA) in Premature Infants With Respiratory Distress Syndrome.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University Hospital Tuebingen · Academic / Other
Sex
All
Age
2 Days
Healthy volunteers
Not accepted

Summary

For therapy of respiratory distress syndrome (RDS) in premature babies, there are several established options. An important therapeutic aspect is the tracheal administration of exogenous surfactant into the child's lung. In the recent years, several methods have been developed. The methods differ in the selected ventilation mode (intubation with mechanical ventilation vs. Continous Positive Airway Pressure (CPAP)-supported spontaneous breathing) and in the way in which the application of surfactant is technically conducted (via endotracheal tube, endotracheal catheter or nebulization). In selection of ventilation technique, there is an upcoming trend towards less invasive respiratory support via CPAP. While this may increase the rate of complications on the one side (i.e. pneumothorax), it shows much lower oxygen demand and a shorter need for mechanical ventilation on the other side. In the selection of the administration technique, different methods were repeatedly developed to adapt the surfactant administration to the CPAP therapy. In this study, a newly developed and in the European Community now certified (CE-Mark) application aid (Neofact) will be tested for the first time on preterm infants, to verify the feasibility.

Conditions

Interventions

TypeNameDescription
DEVICENeofact application aidThe Neofact application aid is a specifically for the LISA procedure designed guide of a soft catheter and replaces the Magill forceps. Catheter (3.5 Fr.) and guide are already combined and packed together sterile. The catheter tip is marked in black (1cm).

Timeline

Start date
2019-05-13
Primary completion
2019-10-31
Completion
2019-10-31
First posted
2019-09-11
Last updated
2019-11-05

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT04086095. Inclusion in this directory is not an endorsement.

Feasibility Study - Neofact (NCT04086095) · Clinical Trials Directory